DIABETIC KIDNEY DISEASES REVISITED: A NEW PERSPECTIVE FOR A NEW ERA

Para ver esta información, visualizar aquí

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015 Glucagon-like peptide 1 (GLP-1)